Dr. Horvath is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5308 Harroun Rd
Ste 55
Sylvania, OH 43560Phone+1 419-824-6599Fax+1 419-885-3870
Education & Training
University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 1971 - 1973
Johns Hopkins UniversityResidency, Internal Medicine, 1969 - 1971
Lewis Katz School of Medicine at Temple UniversityClass of 1969
Certifications & Licensure
OH State Medical License 1975 - 2016
MI State Medical License 1992 - 2012
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 2002
Clinical Trials
- Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2012 Apr 01
Publications & Presentations
PubMed
- 4 citationsPhase II study of gemcitabine and bevacizumab as first-line treatment in taxane-pretreated, HER2-negative, locally recurrent or metastatic breast cancer.Rachel Borson, Graydon Harker, James Reeves, Thaddeus Beck, Steven Hager
Clinical Breast Cancer. 2012-10-01 - 9 citationsMultiple myeloma and systemic lupus erythematosus in a young woman.Kelechi Okoli, Farzan Irani, William Horvath
Journal of Clinical Rheumatology. 2009-09-01 - 8 citationsPathophysiologic considerations for the interactions between obstructive sleep apnea and sickle hemoglobinopathies.Kelechi Okoli, Farzan Irani, William Horvath
Medical Hypotheses. 2009-05-01
Press Mentions
Hendel: Willing to Go over the Edge to Beat CancerJuly 29th, 2021
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
